Pacific Biosciences of Ca...

NASDAQ: PACB · Real-Time Price · USD
1.31
0.08 (6.50%)
At close: Aug 15, 2025, 3:47 PM

Pacific Biosciences of California Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-309.85M -306.74M -314.25M -181.22M
Depreciation & Amortization
53.34M 26.53M 17.32M 11.59M
Stock-Based Compensation
71.04M 72.12M 78.61M 80.73M
Other Working Capital
-42.75M -27.49M -26.55M 34.24M
Other Non-Cash Items
20.2M 19.29M 9.08M 50.37M
Deferred Income Tax
-205K -11.42M n/a -93.65M
Change in Working Capital
-40.58M -58.96M -53.97M 21M
Operating Cash Flow
-206.06M -259.17M -263.21M -111.18M
Capital Expenditures
-6.19M -8.84M -16.93M -5.93M
Cash Acquisitions
n/a -102K 179K -319.79M
Purchase of Investments
-498.63M -756.57M -442.79M -988.05M
Sales Maturities Of Investments
628.83M 770.12M 575.8M 635.24M
Other Investing Acitivies
n/a n/a -179K n/a
Investing Cash Flow
124M 4.6M 116.08M -678.53M
Debt Repayment
-490K -1.84M -1.61M 895.17M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-50.2M -78.47M n/a -20.44M
Financial Cash Flow
-42.99M 108.89M 9.62M 1.17B
Net Cash Flow
-124.15M -145.18M -137.51M 379.87M
Free Cash Flow
-212.25M -268.02M -280.14M -117.11M